{
  "pmcid": "PMC12036300",
  "pmid": "40295977",
  "title": "The frequencies of CYP2C19*2, *3, and *17 alleles and their impact on the clinical efficacy of doubled maintenance dose of clopidogrel in Syrian patients with coronary artery disease",
  "overall_score": 0.2808175529291232,
  "num_benchmarks": 4,
  "benchmarks": {
    "drug_annotations": {
      "score": 0.0,
      "total_samples": 0,
      "ground_truth_annotations": {
        "count": 0,
        "matched_count": 0,
        "unmatched_count": 0,
        "items": []
      },
      "extra_predictions": {
        "count": 4,
        "items": [
          {
            "variant": "CYP2C19*2",
            "gene": "CYP2C19",
            "drug": "clopidogrel",
            "annotation": {
              "Variant/Haplotypes": "CYP2C19*2",
              "Gene": "CYP2C19",
              "Drug(s)": "clopidogrel",
              "Phenotype Category": "efficacy",
              "Significance": "no",
              "Notes": "No association observed between CYP2C19*2 allele and recurrent ischemic events or CYP2C19*17 allele and bleeding complications after treatment with a doubled maintenance dose of clopidogrel.",
              "Sentence": "CYP2C19*2 and CYP2C19*17 alleles are not associated with increased ischemic events or bleeding complications in patients treated with clopidogrel after percutaneous coronary intervention in Syrian patients.",
              "Alleles": "*2, *17",
              "Metabolizer types": "intermediate metabolizer, normal metabolizer",
              "isPlural": "Are",
              "Is/Is Not associated": "Not associated with",
              "Direction of effect": "",
              "PD/PK terms": "response to",
              "Multiple drugs And/or": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "No association was found between the CYP2C19*2 allele and recurrent ischemic events or between the CYP2C19*17 allele and bleeding complications in patients treated with a doubled maintenance dose of clopidogrel.",
                "The frequency of the CYP2C19*2 allele in our study population (8%) was found to be compatible with that of other populations... But the present study did not confirm an association between MACE incidence and the carrier status of the non-functional CYP2C19*2 allele...",
                "In Syrian patients undergoing PCI, a doubled maintenance dose of clopidogrel (150 mg/day) may help mitigate variability in response due to CYP2C19*2 carrier status, offering potential benefits in optimizing antiplatelet therapy."
              ],
              "_expanded_from_multi_variant": true
            }
          },
          {
            "variant": "CYP2C19*17",
            "gene": "CYP2C19",
            "drug": "clopidogrel",
            "annotation": {
              "Variant/Haplotypes": "CYP2C19*17",
              "Gene": "CYP2C19",
              "Drug(s)": "clopidogrel",
              "Phenotype Category": "efficacy",
              "Significance": "no",
              "Notes": "No association observed between CYP2C19*2 allele and recurrent ischemic events or CYP2C19*17 allele and bleeding complications after treatment with a doubled maintenance dose of clopidogrel.",
              "Sentence": "CYP2C19*2 and CYP2C19*17 alleles are not associated with increased ischemic events or bleeding complications in patients treated with clopidogrel after percutaneous coronary intervention in Syrian patients.",
              "Alleles": "*2, *17",
              "Metabolizer types": "intermediate metabolizer, normal metabolizer",
              "isPlural": "Are",
              "Is/Is Not associated": "Not associated with",
              "Direction of effect": "",
              "PD/PK terms": "response to",
              "Multiple drugs And/or": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "No association was found between the CYP2C19*2 allele and recurrent ischemic events or between the CYP2C19*17 allele and bleeding complications in patients treated with a doubled maintenance dose of clopidogrel.",
                "The frequency of the CYP2C19*2 allele in our study population (8%) was found to be compatible with that of other populations... But the present study did not confirm an association between MACE incidence and the carrier status of the non-functional CYP2C19*2 allele...",
                "In Syrian patients undergoing PCI, a doubled maintenance dose of clopidogrel (150 mg/day) may help mitigate variability in response due to CYP2C19*2 carrier status, offering potential benefits in optimizing antiplatelet therapy."
              ],
              "_expanded_from_multi_variant": true
            }
          },
          {
            "variant": "CYP2C19*3",
            "gene": "CYP2C19",
            "drug": "clopidogrel",
            "annotation": {
              "Variant/Haplotypes": "CYP2C19*3",
              "Gene": "CYP2C19",
              "Drug(s)": "clopidogrel",
              "Phenotype Category": "efficacy",
              "Significance": "not stated",
              "Notes": "CYP2C19*3 allele was absent in the study population.",
              "Sentence": "CYP2C19*3 is not associated with decreased response to clopidogrel in patients undergoing percutaneous coronary intervention in Syrian patients.",
              "Alleles": "",
              "Metabolizer types": "",
              "isPlural": "Is",
              "Is/Is Not associated": "Not associated with",
              "Direction of effect": "",
              "PD/PK terms": "",
              "Multiple drugs And/or": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "The allele frequencies were 8% for CYP2C19*2, 0% for CYP2C19*3, and 17% for CYP2C19*17.",
                "The *CYP2C19*3* allele was absent in our study population, which aligns with the low or diminished frequencies reported in European and Middle Eastern populations.",
                "Overall, two of the 41 patients who were followed up in the study experienced at least one MACE after PCI. One case was from the *CYP2C19*2* allele carrier group and the other was from the non-carrier group."
              ]
            }
          },
          {
            "variant": "CYP2C19*17",
            "gene": "CYP2C19",
            "drug": "clopidogrel",
            "annotation": {
              "Variant/Haplotypes": "CYP2C19*17",
              "Gene": "CYP2C19",
              "Drug(s)": "clopidogrel",
              "Phenotype Category": "toxicity",
              "Significance": "no",
              "Notes": "No significant association found between CYP2C19*17 allele and increased bleeding complications in patients treated with clopidogrel after PCI.",
              "Sentence": "CYP2C19*17 is not associated with increased bleeding events in patients treated with clopidogrel in Syrian patients.",
              "Alleles": "",
              "Metabolizer types": "",
              "isPlural": "Is",
              "Is/Is Not associated": "Not associated with",
              "Direction of effect": "",
              "PD/PK terms": "bleeding events",
              "Multiple drugs And/or": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "No association was found between the CYP2C19*2 allele and recurrent ischemic events or between the CYP2C19*17 allele and bleeding complications in patients treated with a doubled maintenance dose of clopidogrel.",
                "The frequency of CYP2C19*17 allele was found to be (17%), which is close to that reported in European and Middle Eastern populations but higher than those found in other studies on Asians (from 0.3% in Koreans to 1.3% in Japanese).",
                "Despite 30% of the individuals carrying the gain-of-function CYP2C19*17 allele and receiving a double maintenance dose of clopidogrel after stent placement, the occurrence of hemorrhagic events remained relatively low, not exceeding (9.7%)."
              ]
            }
          }
        ]
      }
    },
    "phenotype_annotations": {
      "score": 0.4954296155936187,
      "total_samples": 6,
      "ground_truth_annotations": {
        "count": 6,
        "matched_count": 4,
        "unmatched_count": 2,
        "items": [
          {
            "matched": true,
            "overall_match_score": 0.8796256303787231,
            "annotation": {
              "Variant/Haplotypes": "CYP2C19*2",
              "Gene": "CYP2C19",
              "Drug(s)": "clopidogrel",
              "Phenotype Category": "Efficacy",
              "Alleles": "*1/*2 + *2/*2 + *2/*17",
              "Is/Is Not associated": "Not associated with",
              "Direction of effect": "increased",
              "Phenotype": "Side Effect:Major Adverse Cardiac Events (MACE)",
              "When treated with/exposed to/when assayed with": "when treated with",
              "Comparison Allele(s) or Genotype(s)": "*1/*1"
            },
            "field_comparison": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2C19*2",
                "prediction": "CYP2C19*2",
                "score": 1.0,
                "match_status": "match"
              },
              "Gene": {
                "ground_truth": "CYP2C19",
                "prediction": "CYP2C19",
                "score": 1.0,
                "match_status": "match"
              },
              "Drug(s)": {
                "ground_truth": "clopidogrel",
                "prediction": "Clopidogrel",
                "score": 0.9729046821594238,
                "match_status": "match"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "efficacy",
                "score": 1.0,
                "match_status": "match"
              },
              "Alleles": {
                "ground_truth": "*1/*2 + *2/*2 + *2/*17",
                "prediction": "*1/*2",
                "score": 0.9719905853271484,
                "match_status": "match"
              },
              "Is/Is Not associated": {
                "ground_truth": "Not associated with",
                "prediction": "Not associated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Major Adverse Cardiac Events (MACE)",
                "prediction": "major adverse cardiovascular events",
                "score": 0.9549291133880615,
                "match_status": "match"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": "CYP2C19*1 (wild-type)",
                "score": 0.8964319229125977,
                "match_status": "partial_match"
              }
            }
          },
          {
            "matched": true,
            "overall_match_score": 0.7719752669334412,
            "annotation": {
              "Variant/Haplotypes": "CYP2C19*17",
              "Gene": "CYP2C19",
              "Drug(s)": "clopidogrel",
              "Phenotype Category": "Efficacy",
              "Alleles": "*1/*2 + *2/*2 + *2/*17",
              "Is/Is Not associated": "Not associated with",
              "Direction of effect": "increased",
              "Phenotype": "Side Effect:Major Adverse Cardiac Events (MACE)",
              "When treated with/exposed to/when assayed with": "when treated with",
              "Comparison Allele(s) or Genotype(s)": "*1/*1"
            },
            "field_comparison": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2C19*17",
                "prediction": "CYP2C19*17",
                "score": 1.0,
                "match_status": "match"
              },
              "Gene": {
                "ground_truth": "CYP2C19",
                "prediction": "CYP2C19",
                "score": 1.0,
                "match_status": "match"
              },
              "Drug(s)": {
                "ground_truth": "clopidogrel",
                "prediction": "Clopidogrel",
                "score": 0.9729046821594238,
                "match_status": "match"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "toxicity",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Alleles": {
                "ground_truth": "*1/*2 + *2/*2 + *2/*17",
                "prediction": "*1/*17",
                "score": 0.9709437489509583,
                "match_status": "match"
              },
              "Is/Is Not associated": {
                "ground_truth": "Not associated with",
                "prediction": "Not associated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Major Adverse Cardiac Events (MACE)",
                "prediction": "bleeding events",
                "score": 0.8794723153114319,
                "match_status": "partial_match"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": "CYP2C19*1 (wild-type)",
                "score": 0.8964319229125977,
                "match_status": "partial_match"
              }
            }
          },
          {
            "matched": true,
            "overall_match_score": 0.7796256303787231,
            "annotation": {
              "Variant/Haplotypes": "CYP2C19*1",
              "Gene": "CYP2C19",
              "Drug(s)": "clopidogrel",
              "Phenotype Category": "Efficacy",
              "Alleles": "*1/*2 + *2/*2 + *2/*17",
              "Is/Is Not associated": "Not associated with",
              "Direction of effect": "increased",
              "Phenotype": "Side Effect:Major Adverse Cardiac Events (MACE)",
              "When treated with/exposed to/when assayed with": "when treated with",
              "Comparison Allele(s) or Genotype(s)": "*1/*1"
            },
            "field_comparison": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2C19*1",
                "prediction": "(rs4244285)",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Gene": {
                "ground_truth": "CYP2C19",
                "prediction": "CYP2C19",
                "score": 1.0,
                "match_status": "match"
              },
              "Drug(s)": {
                "ground_truth": "clopidogrel",
                "prediction": "Clopidogrel",
                "score": 0.9729046821594238,
                "match_status": "match"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "efficacy",
                "score": 1.0,
                "match_status": "match"
              },
              "Alleles": {
                "ground_truth": "*1/*2 + *2/*2 + *2/*17",
                "prediction": "*1/*2",
                "score": 0.9719905853271484,
                "match_status": "match"
              },
              "Is/Is Not associated": {
                "ground_truth": "Not associated with",
                "prediction": "Not associated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Major Adverse Cardiac Events (MACE)",
                "prediction": "major adverse cardiovascular events",
                "score": 0.9549291133880615,
                "match_status": "match"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": "CYP2C19*1 (wild-type)",
                "score": 0.8964319229125977,
                "match_status": "partial_match"
              }
            }
          },
          {
            "matched": true,
            "overall_match_score": 0.676228380203247,
            "annotation": {
              "Variant/Haplotypes": "CYP2C19*1",
              "Gene": "CYP2C19",
              "Drug(s)": "clopidogrel",
              "Phenotype Category": "Efficacy",
              "Alleles": "*1/*17 + *17/*17 + *2/*17",
              "Is/Is Not associated": "Not associated with",
              "Direction of effect": "increased",
              "Phenotype": "Side Effect:Hemorrhage",
              "When treated with/exposed to/when assayed with": "when treated with",
              "Comparison Allele(s) or Genotype(s)": "*1/*1"
            },
            "field_comparison": {
              "Variant/Haplotypes": {
                "ground_truth": "CYP2C19*1",
                "prediction": "(rs12248560)",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Gene": {
                "ground_truth": "CYP2C19",
                "prediction": "CYP2C19",
                "score": 1.0,
                "match_status": "match"
              },
              "Drug(s)": {
                "ground_truth": "clopidogrel",
                "prediction": "Clopidogrel",
                "score": 0.9729046821594238,
                "match_status": "match"
              },
              "Phenotype Category": {
                "ground_truth": "Efficacy",
                "prediction": "toxicity",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Alleles": {
                "ground_truth": "*1/*17 + *17/*17 + *2/*17",
                "prediction": "*1/*17",
                "score": 0.9783326387405396,
                "match_status": "match"
              },
              "Is/Is Not associated": {
                "ground_truth": "Not associated with",
                "prediction": "Not associated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Direction of effect": {
                "ground_truth": "increased",
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Phenotype": {
                "ground_truth": "Side Effect:Hemorrhage",
                "prediction": "bleeding events",
                "score": 0.9146145582199097,
                "match_status": "partial_match"
              },
              "When treated with/exposed to/when assayed with": {
                "ground_truth": "when treated with",
                "prediction": "when treated with",
                "score": 1.0,
                "match_status": "match"
              },
              "Comparison Allele(s) or Genotype(s)": {
                "ground_truth": "*1/*1",
                "prediction": "CYP2C19*1 (wild-type)",
                "score": 0.8964319229125977,
                "match_status": "partial_match"
              }
            }
          },
          {
            "matched": false,
            "annotation": {
              "Variant Annotation ID": 1454052160,
              "Variant/Haplotypes": "CYP2C19*2",
              "Gene": "CYP2C19",
              "Drug(s)": "clopidogrel",
              "PMID": 40295977,
              "Phenotype Category": "Efficacy",
              "Significance": "no",
              "Notes": "Our results indicated that carriers of the CYP2C19*17 variant experienced a higher incidence of bleeding events (16.67%) compared to non-carriers (6.9%). Despite this observed difference, it is important to note that the statistical analysis found no significant difference between the two groups (P = 0.567; see Table 7). Similarly, there was no statistically significant difference in bleeding events between CYP2C19*2 carriers and non-carriers (P = 0.0952; see Table 7), although a higher proportion of bleeding events was observed among carriers.",
              "Sentence": "CYP2C19 *1/*17 + *17/*17 + *2/*17 is not associated with increased likelihood of Hemorrhage when treated with clopidogrel as compared to CYP2C19 *1/*1.",
              "Alleles": "*1/*17 + *17/*17 + *2/*17",
              "Specialty Population": null,
              "Metabolizer types": null,
              "isPlural": "Is",
              "Is/Is Not associated": "Not associated with",
              "Direction of effect": "increased",
              "Side effect/efficacy/other": "likelihood of",
              "Phenotype": "Side Effect:Hemorrhage",
              "Multiple phenotypes And/or": null,
              "When treated with/exposed to/when assayed with": "when treated with",
              "Multiple drugs And/or": null,
              "Population types": null,
              "Population Phenotypes or diseases": null,
              "Multiple phenotypes or diseases And/or": null,
              "Comparison Allele(s) or Genotype(s)": "*1/*1",
              "Comparison Metabolizer types": null,
              "PMID_norm": "40295977",
              "Variant Annotation ID_norm": "1454052160",
              "_expanded_from_multi_variant": true
            }
          },
          {
            "matched": false,
            "annotation": {
              "Variant Annotation ID": 1454052160,
              "Variant/Haplotypes": "CYP2C19*17",
              "Gene": "CYP2C19",
              "Drug(s)": "clopidogrel",
              "PMID": 40295977,
              "Phenotype Category": "Efficacy",
              "Significance": "no",
              "Notes": "Our results indicated that carriers of the CYP2C19*17 variant experienced a higher incidence of bleeding events (16.67%) compared to non-carriers (6.9%). Despite this observed difference, it is important to note that the statistical analysis found no significant difference between the two groups (P = 0.567; see Table 7). Similarly, there was no statistically significant difference in bleeding events between CYP2C19*2 carriers and non-carriers (P = 0.0952; see Table 7), although a higher proportion of bleeding events was observed among carriers.",
              "Sentence": "CYP2C19 *1/*17 + *17/*17 + *2/*17 is not associated with increased likelihood of Hemorrhage when treated with clopidogrel as compared to CYP2C19 *1/*1.",
              "Alleles": "*1/*17 + *17/*17 + *2/*17",
              "Specialty Population": null,
              "Metabolizer types": null,
              "isPlural": "Is",
              "Is/Is Not associated": "Not associated with",
              "Direction of effect": "increased",
              "Side effect/efficacy/other": "likelihood of",
              "Phenotype": "Side Effect:Hemorrhage",
              "Multiple phenotypes And/or": null,
              "When treated with/exposed to/when assayed with": "when treated with",
              "Multiple drugs And/or": null,
              "Population types": null,
              "Population Phenotypes or diseases": null,
              "Multiple phenotypes or diseases And/or": null,
              "Comparison Allele(s) or Genotype(s)": "*1/*1",
              "Comparison Metabolizer types": null,
              "PMID_norm": "40295977",
              "Variant Annotation ID_norm": "1454052160",
              "_expanded_from_multi_variant": true
            }
          }
        ]
      },
      "extra_predictions": {
        "count": 0,
        "items": []
      }
    },
    "functional_analysis": {
      "score": 0.0,
      "total_samples": 0,
      "ground_truth_annotations": {
        "count": 0,
        "matched_count": 0,
        "unmatched_count": 0,
        "items": []
      },
      "extra_predictions": {
        "count": 0,
        "items": []
      }
    },
    "study_parameters": {
      "score": 0.6609433412551879,
      "total_samples": 2,
      "ground_truth_annotations": {
        "count": 2,
        "matched_count": 2,
        "unmatched_count": 0,
        "items": [
          {
            "matched": true,
            "overall_match_score": 0.6409457886920256,
            "annotation": {
              "Study Parameters ID": 1454052180,
              "Variant Annotation ID": 1454052160,
              "Study Type": null,
              "Study Cases": 41.0,
              "Study Controls": null,
              "Characteristics": "Bleeding events, DAPT with a double maintenance dose of clopidogrel 150 mg/day (for at least one month after PCI).",
              "Characteristics Type": "Study Cohort",
              "Frequency In Cases": 0.17,
              "Allele Of Frequency In Cases": "*17",
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": "= 0.567",
              "Ratio Stat Type": null,
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "Near Eastern"
            },
            "field_comparison": {
              "Study Parameters ID": {
                "ground_truth": 1454052180,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Variant Annotation ID": {
                "ground_truth": 1454052160,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Cases": {
                "ground_truth": 41.0,
                "prediction": 50,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Characteristics": {
                "ground_truth": "Bleeding events, DAPT with a double maintenance dose of clopidogrel 150 mg/day (for at least one month after PCI).",
                "prediction": "Syrian CAD patients treated with dual antiplatelet therapy (DAPT) using a doubled maintenance dose of clopidogrel (150 mg/day) after PCI",
                "score": 0.9619601368904114,
                "match_status": "match"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort",
                "score": 1.0,
                "match_status": "match"
              },
              "Frequency In Cases": {
                "ground_truth": 0.17,
                "prediction": 0.17,
                "score": 1.0,
                "match_status": "match"
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": "*17",
                "prediction": "CYP2C19*17",
                "score": 0.9341182708740234,
                "match_status": "partial_match"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "P Value": {
                "ground_truth": "= 0.567",
                "prediction": "= 0.567",
                "score": 1.0,
                "match_status": "match"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Biogeographical Groups": {
                "ground_truth": "Near Eastern",
                "prediction": "Unknown",
                "score": 0.0,
                "match_status": "no_match"
              }
            }
          },
          {
            "matched": true,
            "overall_match_score": 0.5254248135230121,
            "annotation": {
              "Study Parameters ID": 1454052120,
              "Variant Annotation ID": 1454052100,
              "Study Type": null,
              "Study Cases": 41.0,
              "Study Controls": null,
              "Characteristics": "MACE, DAPT with a double maintenance dose of clopidogrel 150 mg/day (for at least one month after PCI).",
              "Characteristics Type": "Study Cohort",
              "Frequency In Cases": 0.08,
              "Allele Of Frequency In Cases": "*2",
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": "= 0.2744",
              "Ratio Stat Type": null,
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "Near Eastern"
            },
            "field_comparison": {
              "Study Parameters ID": {
                "ground_truth": 1454052120,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Variant Annotation ID": {
                "ground_truth": 1454052100,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Type": {
                "ground_truth": null,
                "prediction": "cohort",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Cases": {
                "ground_truth": 41.0,
                "prediction": 50,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Characteristics": {
                "ground_truth": "MACE, DAPT with a double maintenance dose of clopidogrel 150 mg/day (for at least one month after PCI).",
                "prediction": "MAPC and bleeding complications in Syrian CAD patients treated with a doubled maintenance dose of clopidogrel",
                "score": 0.9322218298912048,
                "match_status": "partial_match"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort",
                "score": 1.0,
                "match_status": "match"
              },
              "Frequency In Cases": {
                "ground_truth": 0.08,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": "*2",
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "P Value": {
                "ground_truth": "= 0.2744",
                "prediction": "= 0.2744",
                "score": 1.0,
                "match_status": "match"
              },
              "Ratio Stat Type": {
                "ground_truth": null,
                "prediction": "Unknown",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Biogeographical Groups": {
                "ground_truth": "Near Eastern",
                "prediction": "Unknown",
                "score": 0.0,
                "match_status": "no_match"
              }
            }
          }
        ]
      },
      "extra_predictions": {
        "count": 1,
        "items": [
          {
            "variant": "N/A",
            "gene": "N/A",
            "drug": "N/A",
            "annotation": {
              "Study Parameters ID": null,
              "Variant Annotation ID": null,
              "Study Type": "cohort",
              "Study Cases": 50,
              "Study Controls": null,
              "Characteristics": "Syrian CAD patients treated with dual antiplatelet therapy (DAPT) using a doubled maintenance dose of clopidogrel (150 mg/day) after PCI",
              "Characteristics Type": "Study Cohort",
              "Frequency In Cases": 0.08,
              "Allele Of Frequency In Cases": "CYP2C19*2",
              "Frequency In Controls": 0,
              "Allele Of Frequency In Controls": "CYP2C19*3",
              "P Value": "> 0.9999",
              "Ratio Stat Type": "Unknown",
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "Unknown",
              "Variant Annotation ID_norm": null
            }
          }
        ]
      }
    }
  }
}